comparemela.com

Latest Breaking News On - கருணா சிகிச்சை இன்க் - Page 3 : comparemela.com

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: Karuna Prices Approximately $250M Public Offering

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: Karuna Prices Approximately $250M Public Offering
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) - The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) - The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia

Posted on 7565 PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, announced that results from the EMERGENT-1 Phase 2 clinical trial evaluating KarXT for the treatment of schizophrenia were published in the New England Journal of Medicine (NEJM). The published manuscript titled “Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia” is available online and appears in the February 25, 2021 issue of

Insider Sells Karuna Therapeutics Stock

  Shares of Karuna Therapeutics Inc (NASDAQ:KRTX) decreased by 1.1% from the previous closing price. Puretech Health Llc filed a Form 4 with the SEC on .

PureTech Adds Bharatt Chowrira, PureTech s President and Chief of Business and Strategy, to Board of Directors

Press release content from Business Wire. The AP news staff was not involved in its creation. PureTech Adds Bharatt Chowrira, PureTech’s President and Chief of Business and Strategy, to Board of Directors January 29, 2021 GMT PureTech announced the appointment of Bharatt Chowrira, Ph.D., J.D., to its Board of Directors. Dr. Chowrira has served as PureTech’s President and Chief of Business and Strategy since March 2017. (Photo: Business Wire) PureTech announced the appointment of Bharatt Chowrira, Ph.D., J.D., to its Board of Directors. Dr. Chowrira has served as PureTech’s President and Chief of Business and Strategy since March 2017. (Photo: Business Wire)

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.